MLEC - Moolec Science SA


9.84
0.580   5.894%

Share volume: 92,885
Last Updated: 03-04-2026
Trading/Investment Offices: 0.03%

PREVIOUS CLOSE
CHG
CHG%

$9.26
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
-4.19%
1 Month
71.13%
3 Months
2,005.71%
6 Months
730.38%
1 Year
1,238.41%
2 Year
465.55%
Key data
Stock price
$9.84
P/E Ratio 
0.00
DAY RANGE
$9.15 - $11.33
EPS 
N/A
52 WEEK RANGE
$0.21 - $23.22
52 WEEK CHANGE
$1,229.73
MARKET CAP 
32.684 M
YIELD 
N/A
SHARES OUTSTANDING 
37.564 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
-0.55
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$133,358
AVERAGE 30 VOLUME 
$3,015,182
Company detail
CEO: Gastón Paladini
Region: US
Website: moolecscience.com
Employees: 4
IPO year: 2023
Issue type: Common Stock
Market: XNAS
Industry: Trading/Investment Offices
Sector: Finance, Insurance, And Real Estate

Moolec Science is a science-based ingredient company focused on producing animal proteins in plants through Molecular Farming. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company’s product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like soybeans and peas.

Recent news